Science news articles about 'breast cancer drug'

LONDON (Reuters) - The most commonly used breast cancer drug may cause tumors to spread in a small number of women with low levels of a protein ...

TRENTON, N.J. (AP) -- GlaxoSmithKline PLC is seeking approval in the U.S. and Europe to sell an existing breast-cancer drug as a first-line treatment....

Women taking the breast cancer drug tamoxifen should avoid taking the antidepressant Paxil because the antidepressant may cancel out the benefits of the cancer treatment, researchers say.

... to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing ... eventually become unresponsive to the drug. Second-line breast cancer therapies are employed when first ...

... to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins ...

... to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins ...

... :52Z WASHINGTON (AP) -- Federal health scientists say follow-up studies of a Roche breast cancer drug show it failed to slow tumor ...

... said Friday that follow-up studies of a Roche breast cancer drug show it failed to slow tumor growth or extend patient lives, opening the door ...

... way of boosting the effectiveness of the anti-breast cancer drug, tamoxifen. The work could open the door to new treatments for those who have developed a resistance to tamoxifen ...

... to aromatase inhibitors (AI), popular breast cancer drugs, are not associated with inflammatory arthritis or autoimmune ... evidence from their tests of inflammatory arthritis in the women with breast cancer. "Although our study helps to rule ...

... can combat this risk factor is by taking the breast cancer drug tamoxifen, which interferes with the activity of estrogen ... omega-3 fatty acids can prevent breast cancer in animals and testing the influence of diet ...

... why some women who take a common breast cancer drug develop serious joint pain ... College of Rheumatology. For many post-menopausal women with breast cancer promoted by the hormone estrogen, aromatase ...

Drug trial involving 1,000 women given Herceptin shows drug is not effective as thought

... become resistant over time to the breast cancer drug tamoxifen. In some tamoxifen-resistant tumors, tamoxifen ... receptor," Shapiro said. "Also important, these compounds are effective in breast cancer cells in which tamoxifen acts like ...

... inhibitors are a mainstay of breast cancer treatment in post-menopausal women. These drugs work by interfering ... a dose-dependent reduction in the effectiveness of the breast cancer drug. Specifically, the tumors began to grow ...